The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Resistance to clopidogrel: A review of the evidence
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Gurbel, P. A., Bliden, K. P., Hiatt, B. L., & O’Connor, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000072771.11429.83 · Cited by 1,544
Matetzky, S., Shenkman, B., Guetta, V., Shechter, M., Beinart, R., Goldenberg, I., Novikov, I., Pres, H., Savion, N., Varon, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130846.46168.03 · Cited by 1,354
Genetic contribution to variable human CYP3A-mediated metabolism
Lamba, J. K., Lin, Y. S., Schuetz, E. G., & Thummel, K. E. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00066-2 · Cited by 990
Variability in platelet responsiveness to clopidogrel among 544 individuals
Serebruany, V. L., Steinhubl, S. R., Berger, P. B., Malinin, A. I., Bhatt, D. L., & Topol, E. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.067 · Cited by 777
Lau, W. C., Waskell, L. A., Watkins, P. B., Neer, C. J., Horowitz, K., Hopp, A. S., Tait, A. R., Carville, D. G. M., Guyer, K. E., & Bates, E. R. (2003) · Circulation · doi:10.1161/01.cir.0000047060.60595.cc · Cited by 688
Central role of the P2Y12 receptor in platelet activation
Dorsam, R. T., & Kunapuli, S. P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420986 · Cited by 594
Müller, I., Besta, F., Schulz, C., Massberg, S., Schönig, A., & Gawaz, M. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613462 · Cited by 585
Lau, W. C., Gurbel, P. A., Watkins, P. B., Neer, C. J., Hopp, A. S., Carville, D. G. M., Guyer, K. E., Tait, A. R., & Bates, E. R. (2004) · Circulation · doi:10.1161/01.cir.0000112378.09325.f9 · Cited by 487
Molecular Basis for ADP-induced Platelet Activation
Jin, J., Daniel, J. L., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2030 · Cited by 477
Structure and Stereochemistry of the Active Metabolite of Clopidogrel
Pereillo, J.-M., Maftouh, M., Andrieu, A., Uzabiaga, M.-F., Fedeli, O., Savi, P., Pascal, M., Herbert, J.-M., Maffrand, J.-P., & Picard, C. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.11.1288 · Cited by 460
Barragan, P., Bouvier, J., Roquebert, P., Macaluso, G., Commeau, P., Comet, B., Lafont, A., Camoin, L., Walter, U., & Eigenthaler, M. (2003) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.10497 · Cited by 434
Fontana, P., Dupont, A., Gandrille, S., Bachelot-Loza, C., Reny, J.-L., Aiach, M., & Gaussem, P. (2003) · Circulation · doi:10.1161/01.cir.0000085073.69189.88 · Cited by 425
Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors
Williams, D., & Feely, J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241050-00003 · Cited by 423
Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance
Cattaneo, M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145980.39477.a9 · Cited by 411
MÜLLER, I., SEYFARTH, M., RÜDIGER, S., WOLF, B., POGATSA-MURRAY, G., SCHÖMIG, A., & GAWAZ, M. (2001) · Heart · doi:10.1136/heart.85.1.92 · Cited by 405
Clarke, T. A., & Waskell, L. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.1.53 · Cited by 374
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting
Bhatt, D. L., Bertrand, M. E., Berger, P. B., L’Allier, P. L., Moussa, I., Moses, J. W., Dangas, G., Taniuchi, M., Lasala, J. M., Holmes, D. R., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01713-2 · Cited by 362
Individual variations of platelet inhibition after loading doses of clopidogrel
Järemo, P., Lindahl, T. L., Fransson, S. G., & Richter, A. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01027.x · Cited by 327
Platelet Function Testing in Cardiovascular Diseases
Michelson, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000147228.29325.f9 · Cited by 317
ANGIOLILLO, D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.036 · Cited by 303
Genetic Variability in CYP3A5 and its Possible Consequences
Xie, H.-G., Wood, A. J., Kim, R. B., Stein, C. M., & Wilkinson, G. R. (2004) · Pharmacogenomics · doi:10.1517/phgs.5.3.243.29833 · Cited by 302
Saw, J., Steinhubl, S. R., Berger, P. B., Kereiakes, D. J., Serebruany, V. L., Brennan, D., & Topol, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000088780.57432.43 · Cited by 267
Jacobsen, W., Kuhn, B., Soldner, A., Kirchner, G., Sewing, K.-F., Kollman, P. A., Benet, L. Z., & Christians, U. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15086-6 · Cited by 236
Geiger, J., Brich, J., Hönig-Liedl, P., Eigenthaler, M., Schanzenbächer, P., Herbert, J. M., & Walter, U. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.8.2007 · Cited by 212
Ding, Z., Kim, S., Dorsam, R. T., Jin, J., & Kunapuli, S. P. (2003) · Blood · doi:10.1182/blood-2002-10-3027 · Cited by 208
Neubauer, H. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00442-1 · Cited by 201
Cattaneo, M., Zighetti, M. L., Lombardi, R., Martinez, C., Lecchi, A., Conley, P. B., Ware, J., & Ruggeri, Z. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437879100 · Cited by 200
Clopidogrel Resistance: A New Chapter in a Fast-Moving Story
Wiviott, S. D., & Antman, E. M. (2004) · Circulation · doi:10.1161/01.cir.0000134701.40946.30 · Cited by 199
Angiolillo, D. J., Fernández‐Ortíz, A., Bernardo, E., Barrera-Ramírez, C. F., Sabaté, M., Fernández, C., Hernández‐Antolín, R., Escaned, J., Alfonso, F., & Macaya, C. (2004) · PubMed · Cited by 187
Macchi, L., Christiaens, L., Brabant, S., Sorel, N., Allal, J., Mauco, G., & Brizard, A. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00210-4 · Cited by 180
Xiao, Z., & Théroux, P. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.071 · Cited by 177
Transon, C., Leemann, T., & Dayer, P. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050094 · Cited by 173
P2Y 12 H2 Haplotype Is Associated With Peripheral Arterial Disease: A Case-Control Study
Fontana, P., Gaussem, P., Aiach, M., Fiessinger, J.-N., Emmerich, J., & Reny, J.-L. (2003) · Circulation · doi:10.1161/01.cir.0000106904.80795.35 · Cited by 164
ADP and platelets: the end of the beginning
Woulfe, D. S., Yang, J., & Brass, L. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13361 · Cited by 158
Schafer, A. I. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80077-5 · Cited by 158
Serebruany, V. L., Midei, M. G., Malinin, A. I., Oshrine, B. R., Lowry, D. R., Sane, D. C., Tanguay, J., Steinhubl, S. R., Berger, P. B., O’Connor, C. M., et al. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.18.2051 · Cited by 154
The difference between clopidogrel responsiveness and posttreatment platelet reactivity
Samara, W. M., Bliden, K. P., Tantry, U. S., & Gurbel, P. A. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.07.002 · Cited by 148
Mitsios, J. V., Papathanasiou, A. I., Rodis, F. I., Elisaf, M., Goudevenos, J. A., & Tselepis, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000124581.18191.15 · Cited by 144
Platelet inhibitor agents in cardiovascular disease: An update
Stein, B., Fuster, V., Israel, D. H., Cohen, M. M., Badimón, L., Badimón, J. J., & Chesebro, J. H. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90453-1 · Cited by 142
Durability of platelet inhibition by clopidogrel
Gurbel, P. A., & Bliden, K. P. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00163-2 · Cited by 131
Mobley, J. E., Bresee, S. J., Wortham, D. C., Craft, R. M., Snider, C. C., & Carroll, R. C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.042 · Cited by 129
Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel
Müller, I. I., Besta, F., Schulz, C., Li, Z., Maßberg, S., & Gawaz, M. (2003) · Circulation · doi:10.1161/01.cir.0000099507.32936.c0 · Cited by 126
Makkar, R. R. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1042 · Cited by 120
Genetics of the Variable Expression of CYP3A in Humans
Wojnowski, L. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00019 · Cited by 118
Single-dose pharmacodynamics of clopidogrel
Wallis, D. E., Lewis, B. E., & Walenga, J. M. (2000) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/s1053-0770(00)90075-2 · Cited by 117
Vivekananthan, D. P., Bhatt, D. L., Chew, D. P., Zidar, F. J., Chan, A. W., Moliterno, D. J., Ellis, S. G., & Topol, E. J. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.04.035 · Cited by 110
Platelet Anti-Aggregating Activity and Tolerance of Clopidogrel in Atherosclerotic Patients
Boneu, B., Destelle, G., & on behalf of the Study Group (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650689 · Cited by 108
Lepäntalo, A. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.12.016 · Cited by 108
Soffer, D. E., Moussa, I. D., Harjai, K. J., Boura, J., Dixon, S. R., Grines, C. L., O’Neill, W. W., Roubin, G. S., & Moses, J. W. (2003) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.10494 · Cited by 99
GORCHAKOVA, O., von Beckerath, N., Gawaz, M., Mocz, A., Joost, A., Schömig, A., & Kastrati, A. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.039 · Cited by 96
Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis
Conley, P. B., & Delaney, S. M. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200309000-00002 · Cited by 76
Prothrombotic and antithrombotic pathways in acute coronary syndromes
Selwyn, A. P. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00428-4 · Cited by 59
Statins do not affect platelet inhibition with clopidogrel during coronary stenting
Serebruany, V. L., Malinin, A. I., Callahan, K. P., Gurbel, P. A., & Steinhubl, S. R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00606-2 · Cited by 55
Cited by
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Global Vascular Guidelines on the management of chronic limb-threatening ischemia.
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.02.016 · Cited by 2,015
Authors/Task Force Members, Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A. A., Hasdai, D., Ohman, E. M., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm161 · Cited by 1,849
Global vascular guidelines on the management of chronic limb-threatening ischemia
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.05.006 · Cited by 1,582
Hulot, J.-S. (2006) · Blood · doi:10.1182/blood-2006-04-013052 · Cited by 931
Metadata
- Authors
- Nguyen, T. A., Diodati, J. G., & Pharand, C.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 45
- Issue
- 8
- Pages
- 1157-1164
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2085190889
- Cited by
- 520
- References
- 58
- FWCI
- 29.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.